Comparison of Clinical Effects of Propranolol (Inderal ®) with Once Daily Slow-Release Oxprenolol (Slow Trasicor®) in Angina Pectoris

Abstract

In a double-blind, crossover, randomized study, the therapeutic effectiveness of a single daily dose of slow-release oxprenolol (160 mg/day) was compared with a conventional dosage schedule of propranolol (40 mg three times daily) in eighteen patients with uncomplicated, stable exercise-induced angina pectoris. Compared to control values both drugs produced equipotent reduction in the frequency and severity of anginal attacks accompanied by a significant increase in exercise tolerance, a significant suppression of exercising heart rate and an appreciable reduction in the electrocardiographic evidence of myocardial ischaemia when tested on a treadmill. The possible advantages offered by a single dose treatment with slow-release oxprenolol are discussed.

Get full access to this article

View all access options for this article.

References

Blackburn

Katigbak

Mitchell

Imbibo

(1964) What electrocardiographic leads to take after exercise? A merican Heart Journal 67, 184.

Bruce

R A

Hornston

T R

(1969) Exercise stress in evaluation of patients with ischaemic heart disease. Progress in Cardiovascular Diseases 2, 371.

Davidson

Thadani

Taylor

S H

Reiss

Hess

(1976) Pharmacological studies with slow-release formulations of oxprenolol in man. European Journal of Clinical Pharmacology 10, 189.

Elliott

W C

Stone

J M

(1969) Beta-adrenergic blocking agents for the treatment of angina pectoris. Progress in Cardiovascular Diseases 12, 83.

Epstein

S E

Stampfer

Beiser

G D

Goldstein

R E

Braunwald

(1969) Effect in reduction of environmental temperature on the circulatory response to exercise in man: Implications concerning angina pectoris. New England Journal of Medicine 280, 7.

Meier

(1970) Effect of oxprenolol on cardiac contractile force, heart rate and coronary circulation. Postgraduate Medical Journal (Nov Suppl), 15.

Multicentre International Study (1975) Improvement of prognosis of myocardial infarction by long-term beta-adrenoceptor blockade using practolol. British Medical Journal 3, 735.

Prichard

B N C

Gillam

P M S

(1971) An assessment of propranolol in angina pectoris. A clinical dose-response curve and the effect on electrocardiogram at rest and on exercise. British Heart Journal 33, 473.

Rivier

J L

(1974) Beta-blockers in the treatment of angina pectoris. In: Beta-blockers: Present status and future prospects. (Ed Schweizer

), p 193. Hans Huber Publishers, Berne.

10.

Sharma

Majid

P A

Galvin

M C

Taylor

S H

(1970) Circulatory and electrocardiographic effects of oxprenolol in angina pectoris. Postgraduate Medical Journal (Nov Suppl), 72.

11.

Sharma

Majid

P A

Taylor

S H

(1978) Haemodynamic factors associated with the production of pain in angina pectoris. European Journal of Cardiology 6/5, 367.

12.

Taylor

S H

Thadani

Watt

S J

Goldstraw

P W

Hess

Reiss

(1976) Studies with slow-release oxprenolol-II: acute and chronic administration to patients with exercise-induced angina pectoris. In: Topics in Cardiovascular Disease (Ed Judd

), p 131. Publishers Ciba Laboratories, Horsham.

13.

Thadani

Sharma

Meeran

M K

Majid

P A

Whitaker

Taylor

S H

(1973) Comparison of adrenergic beta-receptor antagonists in angina pectoris. British Medical Journal 1, 138.

14.

Tuckman

Graham

B R

Abu Saba'a

H M A

Prichard

B N C

(1976) Duration of beta-blockade after single oral doses of slow-release and conventional oxprenolol in six normal males. In: Topics in Cardiovascular Disease (Ed Judd

), p 93. Publishers Ciba Laboratories, Horsham.

15.

West

M J

Kendall

M J

Mitchard

Faragher

E B

(1976) A comparison of slow-release oxprenolol with conventional oxprenolol: Plasma concentrations and clinical effects. British Journal of Clinical Pharmacology 3, 499.